There’s a paradigm shift taking place: We’re moving from an organ-focused (type of cancer) approach to a gene-focused approach (cancer genomics). This shift is already having a profound effect on the way cancer is treated and allows doctors to provide more individualized options for patients (also known as precision medicine). NFCR has distinguished itself from other organizations by emphasizing long-term, transformative research and working to move people toward cancer genomics.
NFCR-funded researchers are all, in some way, using cancer genomics, but there are still certain cancer types that are most impacted by their projects. Specifics about those projects – as well as the cancer diagnoses – are outlined on the “Cancer Types” pages below.
